-
Primers and probes.
Table 3 indicates primers and probes designed for the 16S rRNA RT-qPCR, the primers described by Fyfe et al., and a re-designed hydrolysis probe used for the amplification,... -
Characteristics of included trials.
PI, plaque index; GI, gingival index; PPD, probing pocket depth; CAL, clinical attachment loss; GR, gingival recession; BOP, bleeding on probing; NA, not available; CHX,... -
r37980778c78--eb3527bf3e5cad6607c12579e79d6f12
Results of two-sample Kolmogorov-Smirnov tests for both versions of the reduced model. -
dedup_wf_001--efb227cd3e5d48fa3510e16e948fcbb2
Predicted side effects of drugs. The list of 11,152 novel side effects of drugs spanning 39 drugs and 1,598 side effects. (XLSX 179 kb) -
Additional file 2: of Drug voyager: a computational platform for exploring un...
Predicted drug indications. The list of 1,816 novel drug indications spanning 47 drugs and 122 diseases. (XLSX 54 kb) -
Adverse Events.
Abbreviations: AZA, azathioprine; IFN, interferon; PY, person-years. 1P-values for AZA vs. IFN comparison were obtained through χ2 test with one degree of freedom for rate... -
Drug voyager: a computational platform for exploring unintended drug action
Abstract Background The dominant paradigm in understanding drug action focuses on the intended therapeutic effects and frequent... -
Incorporating pharmacodynamic considerations into caffeine therapeutic drug m...
Background This study sought to assess the pharmacokinetic and pharmacodynamic relationships of caffeine citrate therapy in preterm neonates who had therapeutic drug monitoring... -
Demographic and clinical characteristics of the study population.
Note: IQR: interquartile range. HAART: highly active antiretroviral therapy. HCV: hepatitis C virus infection. ADE: AIDS-defining event. ART: antiretroviral therapy.... -
Characteristics of included studies.
RCT: Randomised controlled trial. GS: Gilead Sciences. R: Roche. GSK: GlaxoSmithKline. NS: not stated. aCopies/mL converted to IU/mL by dividing by 5.bThe limit of detection of...